Gambaran Umum
Santen Pharmaceutical Co., Ltd., based in Japan, is a renowned entity in the pharmaceutical industry, particularly recognized for its focus on ophthalmology. The company is dedicated to the development, production, and marketing of pharmaceutical products, over-the-counter drugs, and medical devices, primarily for eye care. Key projects encompass a broad range of therapies for ocular diseases, including glaucoma, dry eye, and retinal diseases. Santen's commitment to innovation is evident in its extensive R&D initiatives, aiming to bring forth advanced solutions for eye health worldwide. The company's strategic approach combines global expansion with a solid domestic presence, making it a significant player in the international pharmaceutical landscape.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 293,970.00 MM.
- Nilai operating income untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 43,699.00 MM.
- Nilai net income untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 31,501.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 293,970.00 | 43,699.00 | 31,501.00 |
| 2025-03-31 | 300,004.00 | 48,295.00 | 36,256.00 |
| 2024-12-31 | 301,905.00 | 51,223.00 | 27,494.00 |
| 2024-09-30 | 302,563.00 | 50,959.00 | 26,133.00 |
| 2024-06-30 | 304,347.00 | 52,591.00 | 26,861.00 |
| 2024-03-31 | 301,965.00 | 38,540.00 | 26,642.00 |
| 2023-12-31 | 302,084.00 | 81,605.00 | 27,729.00 |
| 2023-09-30 | 295,928.00 | 79,419.00 | 26,374.00 |
| 2023-06-30 | 285,893.00 | 39,716.00 | -11,197.00 |
| 2023-03-31 | 279,037.00 | 35,300.00 | -14,948.00 |
| 2022-12-31 | 270,242.00 | -651.00 | -8,195.00 |
| 2022-09-30 | 266,413.00 | -1,951.00 | -9,130.00 |
| 2022-06-30 | 266,804.00 | 35,053.00 | 26,539.00 |
| 2022-03-31 | 266,257.00 | 35,875.00 | 27,218.00 |
| 2021-12-31 | 263,620.00 | 52,619.00 | 5,062.00 |
| 2021-09-30 | 259,459.00 | 53,627.00 | 7,324.00 |
| 2021-06-30 | 257,028.00 | 54,648.00 | 7,983.00 |
| 2021-03-31 | 249,605.00 | 53,508.00 | 6,830.00 |
| 2020-12-31 | 241,015.00 | 38,185.00 | 24,434.00 |
| 2020-09-30 | 241,685.00 | 39,536.00 | 24,283.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 77.66 | 77.39 |
| 2024-09-30 | 73.26 | 73.03 |
| 2024-06-30 | 73.88 | 73.64 |
| 2024-03-31 | 72.62 | 72.37 |
| 2023-12-31 | 74.79 | 74.66 |
| 2023-09-30 | 69.65 | 69.58 |
| 2023-06-30 | -29.38 | -29.37 |
| 2023-03-31 | -38.60 | -38.60 |
| 2022-12-31 | -20.85 | -20.87 |
| 2022-09-30 | -23.03 | -23.04 |
| 2022-06-30 | 66.49 | 66.39 |
| 2022-03-31 | 68.07 | 67.97 |
| 2021-12-31 | 12.65 | 12.64 |
| 2021-09-30 | 18.32 | 18.29 |
| 2021-06-30 | 19.97 | 19.94 |
| 2021-03-31 | 17.09 | 17.06 |
| 2020-12-31 | 61.17 | 61.04 |
| 2020-09-30 | 60.80 | 60.66 |
| 2020-06-30 | 58.62 | 58.48 |
| 2020-03-31 | 59.16 | 59.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 56,509.00 MM.
- Nilai cash from investing activities untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -9,399.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Santen Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -49,713.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 56,509.00 | -9,399.00 | -49,713.00 |
| 2025-03-31 | 60,928.00 | -8,223.00 | -53,307.00 |
| 2024-12-31 | 55,247.00 | -7,663.00 | -55,157.00 |
| 2024-09-30 | 73,225.00 | -6,839.00 | -46,597.00 |
| 2024-06-30 | 82,244.00 | -4,461.00 | -39,206.00 |
| 2024-03-31 | 72,649.00 | -6,145.00 | -34,031.00 |
| 2023-12-31 | 68,107.00 | -8,906.00 | -40,546.00 |
| 2023-09-30 | 46,547.00 | -11,750.00 | -40,760.00 |
| 2023-06-30 | 37,272.00 | -23,251.00 | -37,209.00 |
| 2023-03-31 | 37,147.00 | -26,777.00 | -37,220.00 |
| 2022-12-31 | 43,335.00 | -35,532.00 | -18,289.00 |
| 2022-09-30 | 37,279.00 | -36,923.00 | -13,538.00 |
| 2022-06-30 | 45,922.00 | -36,513.00 | -2,042.00 |
| 2022-03-31 | 46,043.00 | -35,169.00 | 5,557.00 |
| 2021-12-31 | 46,172.00 | -26,281.00 | -7,877.00 |
| 2021-09-30 | 47,476.00 | -25,678.00 | -6,942.00 |
| 2021-06-30 | 33,903.00 | -47,673.00 | -16,846.00 |
| 2021-03-31 | 38,808.00 | -53,355.00 | -16,685.00 |
| 2020-12-31 | 36,409.00 | -51,958.00 | -14,171.00 |
| 2020-09-30 | 34,787.00 | -48,001.00 | -13,538.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | |||
| 2020-09-30 | |||
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 | ||
| 2020-09-30 | ||
| 2020-06-30 | ||
| 2020-03-31 |
Efektivitas Manajemen
- roa untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.08.
- roe untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.12.
- roic untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.11.
- croic untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah -0.00.
- ocroic untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.19.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | 0.08 | 0.12 | 0.11 | -0.00 | 0.19 |
| 2025-03-31 | 0.06 | 0.09 | 0.10 | -0.01 | 0.20 |
| 2024-12-31 | 0.06 | 0.09 | 0.09 | 0.07 | 0.25 |
| 2024-09-30 | 0.06 | 0.09 | 0.09 | 0.14 | 0.27 |
| 2024-06-30 | 0.09 | ||||
| 2024-03-31 | 0.09 | ||||
| 2023-12-31 | 0.09 | -0.01 | |||
| 2023-09-30 | -0.04 | -0.07 | |||
| 2023-06-30 | -0.03 | ||||
| 2023-03-31 | -0.04 | ||||
| 2022-12-31 | |||||
| 2022-09-30 | 0.00 | ||||
| 2022-06-30 | 0.00 | 0.00 | |||
| 2022-03-31 | 0.00 | 0.00 | |||
| 2021-12-31 | 0.00 | ||||
| 2021-09-30 | 0.02 | 0.02 | |||
| 2021-06-30 | 0.02 | 0.02 | -0.09 | 0.11 | |
| 2021-03-31 | 0.02 | 0.02 | 0.02 | -0.09 | 0.12 |
| 2020-12-31 | 0.06 | 0.08 | 0.08 | -0.09 | 0.12 |
| 2020-09-30 | 0.06 | 0.08 | 0.07 | -0.08 | 0.11 |
| 2020-06-30 | 0.06 | 0.08 | 0.07 | 0.05 | 0.13 |
| 2020-03-31 | 0.06 | 0.08 | 0.08 | 0.07 | 0.13 |
Gross Margins
- marjin kotor untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.57.
- marjin bersih untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.12.
- marjin operasi untuk Santen Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.16.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.57 | 0.12 | 0.16 |
| 2025-03-31 | 0.57 | 0.09 | 0.17 |
| 2024-12-31 | 0.58 | 0.09 | 0.17 |
| 2024-09-30 | 0.59 | 0.09 | 0.17 |
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | -0.04 | 0.14 | |
| 2023-06-30 | -0.04 | 0.14 | |
| 2023-03-31 | -0.05 | -0.01 | |
| 2022-12-31 | |||
| 2022-09-30 | 0.00 | 0.00 | |
| 2022-06-30 | 0.00 | 0.00 | |
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | 0.61 | 0.03 | 0.21 |
| 2021-03-31 | 0.61 | 0.03 | 0.05 |
| 2020-12-31 | 0.60 | 0.10 | 0.16 |
| 2020-09-30 | 0.60 | 0.10 | 0.16 |
| 2020-06-30 | 0.60 | 0.10 | 0.16 |
| 2020-03-31 | 0.61 | 0.10 | 0.14 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1501108 |
Grupong Pang-industriya
| SIC 2834 - Pharmaceutical Preparations |
